Follow us on

Q of the week

Q: Do clinical trials ever go wrong?

Get the Answer: 


A test to check for cancer of the cervix, the opening to a woman's womb. It is done by removing cells from the cervix. The cells are then prepared so they can be seen under a microscope.

Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 12:12:20
Managing Clinical Trials   by  on 2010-07-15 16:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 10:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 10:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 09:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 09:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 11:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 11:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 01:40:32
The Wall Street Journal's special supplement on clinical trials   by  on 2010-05-01 01:31:52
Major developments in EU Clinical Trial Guidances   by  on 2010-04-20 19:10:55
Analysis of the adverse reactions induced by natural product-derived drugs   by  on 2010-04-18 23:16:06
Newer Antibacterial Drugs for a New Century   by  on 2010-04-18 22:49:47
Newer Non-Statin Drugs for Reducing Cholesterol   by  on 2010-04-13 07:57:20
Practice Guidelines for Chronic Pain Management   by  on 2010-04-04 20:52:16
CONSORT III (2010)   by  on 2010-03-29 12:53:28
US FDA Draft Guidance on Pharmacokinetics in Patients with Impaired Renal Function   by  on 2010-03-20 12:25:16
US-FDA issues First Draft Guidance on Noninferiority Trials   by  on 2010-03-04 14:07:46
US FDA new rule on reporting information regarding falsification of data   by  on 2010-02-25 20:47:33
US-FDA Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials   by  on 2010-02-06 12:12:14
 Subject :Clinical Trial Registry to be upgraded to make it at par with int'l st.. 2009-10-27 09:31:49 
Joined: 2009-07-29 10:23:16
Posts: 9
Subject :Clinical Trial Registry to be upgraded to make it at par with int'l standards

After running the Clinical Trial Registry of India (CTRI) for over two years on a pilot basis in the country, the Indian Council of Medical Research (ICMR) has decided to upgrade the Registry to make it at par with international standards as per the norms set by the WHO.

Several new features as per the requirements of the WHO like audit trail (constant tracking of data) will be included in the new format. The software of the Registry will soon be upgraded to make it automatic, instead of manual checking of the quality parameters, said Dr Abha Agarwal, coordinator at the National Institute of Medical Statistics (NIMS), an arm of ICMR mandated with the responsibility of setting up and maintaining the National Clinical Trials Registry of India.

Dr Agarwal said that as the registration of a clinical trial in the country has been made mandatory by the DCGI, it has been decided to implement a fresh well designed Web Hosted Clinical Trial Registry to meet the expectations of the various stakeholders including the pharmaceutical industry, researchers, publications, administrators and the public at large. Being a front runner, among the first ten across the world, in the implementation of the mandate of registration of clinical trials, the Clinical Trial Registry of India will be keenly monitored across the world.

She said that a lot of changes have to be made in the existing Registry as there are a lot of problems in it which was launched on July 20, 2007. Since the Indian Registry is getting applications from all over the world, it has to be on line with the international standards. In the present Registry, a lot of requirements of the WHO are missing. For example, there is no clause for audit trail in the present Registry without which the authorities will not be able to track the changes constantly in the data of the trial. As the companies very often make changes in the data, it is very necessary to include such a clause in the Registry, Dr Agarwal said.

She said that since the DCGI has made it mandatory to get all new clinical trials registered with the CTRI as a pre-requisite for obtaining permission for clinical trials in the country, there has been a substantial increase in the number of applications. So, the entire system is being upgraded to make it automatic, instead of manual checking of the quality parameters and other criteria.


IP Logged
Page # 

Powered by ccBoard